GLAXOSMITHKLINE PHARMACEUTICALS
|
The Current P/S Ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 12.44.
Share Price | ₹2,721.3 | May 12,2025 |
Market Cap | ₹46,098.0 Cr | |
Sales-TTM | ₹3,704.6 Cr | TTM-Consolidated Results |
Price/Sales | 12.44x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of GLAXOSMITHKLINE PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹46,098.0 Cr] as on May 12,2025
(/) Sales [ ₹3,704.6 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 12.44x ]
Thus, for GLAXOSMITHKLINE PHARMACEUTICALS , the investors are currently willing to pay '12.44 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of GLAXOSMITHKLINE PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of GLAXOSMITHKLINE PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of GLAXOSMITHKLINE PHARMACEUTICALS
PS Ratio Performance Analysis for GLAXOSMITHKLINE PHARMACEUTICALS
- GLAXOSMITHKLINE PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 7.98x.
- GLAXOSMITHKLINE PHARMACEUTICALS 's operated at median p/e ratio of 8.34x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GLAXOSMITHKLINE PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 9.53x.
- GLAXOSMITHKLINE PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 6.54x.
How does GLAXOSMITHKLINE PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
GLAXOSMITHKLINE PHARMACEUTICALS | 3,704.6 | 12.44 | 46,098.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 51,602.5 | 7.84 | 404,588.0 |
DIVIS LABORATORIES LTD | 9,078.0 | 17.37 | 157,711.0 |
CIPLA LTD | 26,981.2 | 4.53 | 122,115.0 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 9.70 | 109,589.0 |
DR REDDYS LABORATORIES LTD | 32,643.9 | 3.06 | 99,746.6 |
MANKIND PHARMA LTD | 11,641.0 | 8.85 | 103,054.0 |
ZYDUS LIFESCIENCES LTD | 22,247.4 | 4.00 | 89,016.5 |
LUPIN LTD | 22,001.6 | 4.24 | 93,193.1 |
AUROBINDO PHARMA LTD | 30,921.8 | 2.27 | 70,044.7 |
ABBOTT INDIA LTD | 6,243.2 | 10.23 | 63,839.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs GLAXOSMITHKLINE PHARMACEUTICALS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.27x |
Max industry PS | 17.37x |
Median industry PS | 7.84x |
Average industry PS | 7.68x |
You may also like the below Video Courses